Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Oleandomycin |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Dirithromycin |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Miokamycin |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Roxithromycin |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Erythromycin (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
antibiotikum indeholdende macrolid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
1 |
Erythromycin or macrolide poisoning NOS |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Macrolide adverse reaction |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
1 |
overdosis af macrolid |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
1 |
Spiramycin (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Clarithromycin (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Azithromycin (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing telithromycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Telithromycin 400mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
forgiftning med erythromycin OG/ELLER anden macrolid |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
1 |
allergi over for antibiotikum indeholdende macrolid |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing carbomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Lincomycin (substance) |
Is a |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Adverse reaction to erythromycin and other macrolides |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Adverse reaction to macrolide NOS |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Adverse reaction to oleandomycin |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Telithromycin 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Ketolide (substance) |
Is a |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Clindamycin phosphate 2% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Clindamycin phosphate 20 mg/mL vaginal cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing clindamycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Clindamycin hydrochloride 75mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Clindamycin hydrochloride 150mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Clindamycin and lincomycin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Clindamycin [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
clindamycinphosphat 150 mg/ml injektionsvæske, opløsning, ampul a 4 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
clindamycinphosphat vagitorium a 100 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Clindamycin phosphate 300mg/50mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Clindamycin phosphate 600mg/50mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Clindamycin phosphate 900mg/50mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
clindamycinpalmitathydrochlorid 75 mg/5 ml suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Clindamycin phosphate 1% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
clindamycinphosphat 1 % opløsning til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing precisely clindamycin hydrochloride 300 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
clindamycinphosphat 150 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
clindamycinphosphat 150 mg/ml injektionsvæske, opløsning, ampul a 6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Clindamycin phosphate 150mg/mL injection solution 4mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
clindamycinphosphat 900 mg/6 ml injektionsvæske, opløsning, hætteglas a 6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing lincomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
lincomycinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing precisely lincomycin hydrochloride 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
lincomycinhydrochlorid 300 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
allergi over for antibiotikum indeholdende macrolid |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
1 |
Acetylspiramycin (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Midecamycin (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Fidaxomicin |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Tylosin (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Carbomycin (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Josamycin (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Rosamicin (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Solithromycin (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Tulathromycin (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Azithromycin dihydrate |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Azithromycin monohydrate (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Erythromycin lactobionate |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Erythromycin dihydrate (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Erythromycin phosphate |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Erythromycin propionate (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Erythromycin stearate |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Erythromycin gluceptate |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Erythromycin ethylsuccinate (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Erythromycin estolate |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Azithromycin overdose |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Accidental azithromycin overdose |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Intentional azithromycin overdose |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Accidental erythromycin overdose |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Allergy to erythromycin |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
2 |
Accidental clarithromycin overdose |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Intentional erythromycin overdose |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Intentional clarithromycin overdose |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
overdosis af clarithromycin, uvist med hvilken hensigt |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Allergy to clarithromycin (finding) |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
2 |
Allergy to azithromycin (finding) |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
2 |
Spiramycin adverse reaction (disorder) |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
overdosis af azithromycin, uvist med hvilken hensigt |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Clarithromycin overdose |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Quinupristin (substance) |
Is a |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Dalfopristin (substance) |
Is a |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Erythromycin adverse reaction (disorder) |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Clarithromycin adverse reaction |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Azithromycin adverse reaction |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Erythromycin overdose |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
overdosis af erythromycin, uvist med hvilken hensigt |
Causative agent |
False |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Erythromycin thiocyanate |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Troleandomycin |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Azithromycin anhydrous |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Cethromycin (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Spiramycin adipate (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Carbomycin A |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Carbomycin B |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Streptogramin (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Midecamycin acetate (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Telithromycin (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Tylosin phosphate |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
14-hydroxyclarithromycin |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Josamycin propionate (substance) |
Is a |
True |
Substance with macrolide structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|